Latest Top Picks

Stock Opinions by Phil Smith

DON'T BUY
Suffered competition by Envidio. Needs a turnaround
BUY
Good stocks. Strong assets. Best growth prospects in integrated oils
BUY ON WEAKNESS
Good company. Fully valued now. Buy at $40. Expanding globally
DON'T BUY
Not a fan of steels. Probably as low as it can go. Could rebound. Prefers Dofasco
WEAK BUY
Not a fan of steels. Good dividend. Prefers over Stelco.
BUY ON WEAKNESS
At its peak. BUY on weakness
BUY ON WEAKNESS
At its peak. BUY on weakness(mid $30's)
DON'T BUY
Volatile. High risk
WAIT
Good growth phase. Has been under pressure.
DON'T BUY
Volatile. High risk
WAIT
A leader. Wait for stabilization.
BUY
Better diversified than a lot of bio techs. Great growth profile.
BUY
Better diversified than a lot of pharmaceuticals
BUY ON WEAKNESS
Possible takeover target. Looks fairly valued in mid/high $20's. Buy on weakness.
DON'T BUY
Near term is a high risk. Won't be a leader in any recovery.
Showing 1 to 15 of 45 entries